Tekla Life Sciences Investors Financial Statements 2011-2024 | HQL

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	392 M	369 M	392 M	439 M	355 M	513 M	454 M	285 M	215 M	163 M
Shares	23.2 M	23.2 M	22.4 M	21.6 M	20.7 M	19.7 M	19 M	15 M	14.4 M	14.6 M
Net Income	123 M	-70.5 M	28.7 M	68.6 M	-11.9 M	40.5 M	89.3 M	84.6 M	77.6 M	37.5 M
Revenue	124 M	2.44 M	1.99 M	1.68 M	1.44 M	1.32 M	880 K	520 K	2.14 M	570 K
EBITDA	-	-138 M	60.9 M	141 M	-20 M	85.7 M	182 M	172 M	157 M	37.5 M
Operating Expenses	-	1.14 M	1.16 M	1.26 M	679 K	397 K	500 K	590 K	950 K	1.35 M
General and Administrative Expenses	751 K	702 K	691 K	832 K	550 K	254 K	370 K	440 K	750 K	1.15 M